Inhaled Insulin, Inhaled Insulin Preparations, New Inhaled Insulin, And Insulin Analogs

Published on July 15, 2014

Afrezza, an insulin product administered with a special inhaler, rather than requiring injection, has just been approved by the United States Food and Drug Administration for pre-meal administration to control blood glucose in people with both type 1 and type 2 diabetes.